NCI’s RPG pool, cancer centers, training awards, SPOREs, and intramural research likely to face cuts in FY24 Center directors are concerned about NCI’s proposal to create a tier of centers with lower eligibility criteria

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models.

April 25, 2025

Vol.51 No.16

By Claire Marie Porter

Cancer Policy

DOGE implements manual review of awarded funds

The Department of Government Efficiency has started requiring HHS grantees to provide justifications in order to receive payouts for already awarded grant money.

NIH notice prohibits grant awardees from operating programs that promote DEI

NIH, in a recent notice, prohibits grant recipients from operating programs that promote DEI or “discriminatory equity ideology,” or engage in “discriminatory prohibited boycott.”

NSF director Sethuraman Panchanathan to resign

Sethuraman Panchanathan, director of the National Science Foundation, will resign from the position 16 months before the scheduled end of his six-year term.

April 25, 2025

Vol.51 No.16

By Jacquelyn Cobb and Claire Marie Porter

Funding Opportunities

2025 AACR-Novocure grants for cancer research now accepting applications

The American Association for Cancer Research-Novocure Career Development Award for Cancer Research represents a joint effort to promote and support early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage early-career investigators to enter the TTFields research field.

April 25, 2025

Vol.51 No.16

NCI’s RPG pool, cancer centers, training awards, SPOREs, and intramural research likely to face cuts in FY24

Center directors are concerned about NCI’s proposal to create a tier of centers with lower eligibility criteria

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

DOGE implements manual review of awarded funds

NIH notice prohibits grant awardees from operating programs that promote DEI

NSF director Sethuraman Panchanathan to resign

2025 AACR-Novocure grants for cancer research now accepting applications

Renew today!

Subscriber content

NCI’s RPG pool, cancer centers, training awards, SPOREs, and intramural research likely to face cuts in FY24

Center directors are concerned about NCI’s proposal to create a tier of centers with lower eligibility criteria

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

DOGE implements manual review of awarded funds

NIH notice prohibits grant awardees from operating programs that promote DEI

NSF director Sethuraman Panchanathan to resign

2025 AACR-Novocure grants for cancer research now accepting applications

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas